RNAi and its application in tumor study

Progress in Biochemistry and Biophysics

Volumn 31, Issue 6, 2004, Pages 492-499

  Shi, Zhi ^a   Fu, Li Wu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Gene silence; RNAi; siRNA; Tumor

Indexed keywords

DOUBLE STRANDED RNA; MESSENGER RNA;

DRUG TARGETING; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR; VALIDATION PROCESS;

EID: 3242798169     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Fire A, Xu S, Montgomery M K, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391 (6669): 806-811
2. Hutvagner G, Zamore P D. RNAi; nature abhors a double-strand. Curr Opin Gene Devel, 2002, 12 (2): 225-232
3. Ramaswamy G, Slack F J. SiRNA: A guide for RNA silencing. Chem Biol, 2002, 9 (10): 1053-1055
4. Hannon G J. RNA interference. Nature, 2002, 418 (6894): 244 -251
5. Elbashir S M, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411 (6836): 494-498
6. MucManus M T, Sharp P A. Gene silencing in mammals by small interfering RNAs. Nature Reviews Genetics, 2002, 3 (10): 737-746
7. Thompson J D. Applications of antisense and siRNAs during preclinical drug development. Drugdiscovery Today, 2002, 7 (17): 912-917
8. Vickers T A, Koo S, Frank Bennett C, et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. J Biol Chem, 2003, 278 (9): 7108-7118
9. Shuey D J, McCallus D E, Giordano T. RNAi: gene-silencng in therapeutic intervention. Drugdiscovery Today, 2002 , 7 (20): 1040-1046
10. Bridge A J, PebernaRd S, Ducraux A, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genetics, 2003, 34 (7): 263-264
11. Yu J Y, DeRuiter S L, Turner D L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA, 2002, 99 (9): 6047-6052
12. Yang D, Buchholz F, Huang Z, et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc Natl Acad Sci USA, 2002, 99 (15): 9942-99477
13. Sui G, Soohoo C, Affar E B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA, 2002, 99 (8): 5515-5520
14. Castanotto D, Li H, Rossi J J. Functional siRNA expression from transfected PCR products. RNA, 2002, 8 (11): 1454-1460
15. Wilda M, Fuchs U, Wossmann W, et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene, 2002, 21 (37): 5716-5724
16. Scherr M, Battmer K, Winkler T, et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood, 2003, 101 (4): 1566-1569
17. Wohlbold L, Kuip H, Miething C, et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood, 2003, 102 (6): 2236-2239
18. Hemann M T, Fridman J S, Zilfou J T, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genetics, 2003, 33 (3): 396-400
19. Ramos-Nino M E, Scapoli L, Martinelli M, et al. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma1. Cancer Res, 2003, 63 (13): 3539-3545
20. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive humane cervical carcinoma cells trested with siRNA, a primer of RNA interference. Oncogene, 2002, 21 (39): 6041-6048
21. Lipscomb E A, Dugan A S, Rabinovitz I, et al. Use of RNA interference to inhibit integrin (α6β4)-mediated invasion and migration of breast carcinoma cells. Clinical Experimental Metastasis, 2003, 20 (3): 569-576
22. Chen Y C, Stamatoyannopoulos G, Song C Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res, 2003, 63 (7): 4801-4804
23. Li T L, Hui C C, Lien C C, et al. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res, 2003, 63 (6): 3069-3072
24. Ahn J, Urist M, Prives C. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J Biol Chem, 2003, 278 (23): 20480-20489
25. Ohtsuka T, Ryu H, Minamishima Y A, et al. Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene, 2003, 22 (11): 1678-1687
26. Yoon H S, Chen X M, Yang V W. Krüppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem, 2003, 278 (4): 2101-2105
27. Wang B, Matsuoka S, Carpenter P B, et al. 53BP1, a mediator of the DNA damage checkpoint. Science, 2002, 298 (5597): 1435 -1438
28. Kip1 and regulates cell cycle progression. EMBO J, 2002, 21 (13): 3390-3401
29. Porter L A, Dellinger R W, Tynan J A, et al. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol, 2002, 157 (3): 357-366
30. Shu X, Wu W, Mosteller R D, et al. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol, 2002, 22 (22): 7758-7768
31. Lu P Y, Xie F Y, Woodle M C, et al. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Curr Opin Mol Ther, 2003, 5 (3): 225-234
32. Uematsu K, He B, You L, et al. Activation of the Wnt pathway in non-small cell lung cancer: evidence of dishevelled overexpression. Oncogene, 2003, 22 (46): 7218-7221
33. Irie N, Sakai N, Ueyama T, et al. Subtype- and species-specie knockdown of PKC using short interfering RNA. Biochem Biophys Res Commun, 2002, 298 (5): 738-743
34. Spankuch-Schmitt B, Bereniter-Hahn J, Kaufmann M, et al. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Nati Cancer Inst, 2002, 94 (24): 1863-1877
35. Czauderna F, Fechtner M, Aygun H, et al. Functional studies of the PI (3) -kinase signaling pathway employing synthetic and expressed siRNA. Nucleic Acids Res, 2003, 31 (2): 670-682
36. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science, 2002, 279 (5585): 1352-1354
37. Zhang D, Li F, Weidner D, et al. Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin, the potential role of MCL as a fortilin chaperone. J Biol Chem, 2002, 277 (40): 37430-37438
38. Jiang M, Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev, 2003, 17 (7): 832-837
39. Cioca D P, Aoki Y, Kiyosawa K. RNA interfering is a functionl pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Therapy, 2003, 10 (3): 125-133
40. Wu H, Hait W N, Yang J M. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein ) restores sensitivity to multidrug-resistant cancer cells. Cancer Res, 2003, 63 (7): 1515 -1519
41. Collis S J, Swartz M J, Nelson W J, et al. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res, 2003, 63 (7): 1550-1554
42. Scadden A D, Smith C W. RNAi is antagonized by A→1 hyper-editing. EMBO Rep, 2001, 2 (12): 1107-1111